Advisor Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $9.47M | Buy |
17,432
+1,130
| +7% | +$622K | 0.67% | 23 |
|
|
2022
Q1 | $9.63M | Sell |
16,302
-537
| -3% | -$308K | 0.6% | 27 |
|
|
2021
Q4 | $11.2M | Sell |
16,839
-497
| -3% | -$310K | 0.68% | 23 |
|
|
2021
Q3 | $9.9M | Sell |
17,336
-446
| -3% | -$245K | 0.67% | 25 |
|
|
2021
Q2 | $8.97M | Sell |
17,782
-235
| -1% | -$111K | 0.59% | 29 |
|
|
2021
Q1 | $8.22M | Sell |
18,017
-710
| -4% | -$339K | 0.59% | 33 |
|
|
2020
Q4 | $8.72M | Buy |
18,727
+115
| +0.6% | +$53.9K | 0.66% | 30 |
|
|
2020
Q3 | $8.22M | Sell |
18,612
-166
| -0.9% | -$68.6K | 0.71% | 30 |
|
|
2020
Q2 | $6.8M | Buy |
18,778
+1,300
| +7% | +$436K | 0.63% | 33 |
|
|
2020
Q1 | $4.96M | Buy |
17,478
+1,841
| +12% | +$581K | 0.6% | 35 |
|
|
2019
Q4 | $5.24M | Buy |
15,637
+897
| +6% | +$272K | 0.54% | 37 |
|
|
2019
Q3 | $4.29M | Buy |
14,740
+1,509
| +11% | +$432K | 0.52% | 38 |
|
|
2019
Q2 | $3.89M | Buy |
13,231
+564
| +4% | +$155K | 0.47% | 42 |
|
|
2019
Q1 | $3.47M | Sell |
12,667
-181
| -1% | -$45K | 0.44% | 45 |
|
|
2018
Q4 | $2.88M | Buy |
12,848
+1,348
| +12% | +$316K | 0.46% | 46 |
|
|
2018
Q3 | $2.81M | Buy |
11,500
+326
| +3% | +$75K | 0.38% | 50 |
|
|
2018
Q2 | $2.31M | Buy |
11,174
+1,050
| +10% | +$223K | 0.39% | 51 |
|
|
2018
Q1 | $2.09M | Buy |
10,124
+839
| +9% | +$176K | 0.39% | 55 |
|
|
2017
Q4 | $1.98M | Buy |
9,285
+758
| +9% | +$145K | 0.35% | 57 |
|
|
2017
Q3 | $1.61M | Buy |
8,527
+379
| +5% | +$68.6K | 0.32% | 64 |
|
|
2017
Q2 | $1.42M | Buy |
8,148
+670
| +9% | +$113K | 0.33% | 71 |
|
|
2017
Q1 | $1.15M | Sell |
7,478
-34
| -0.5% | -$5.2K | 0.31% | 80 |
|
|
2016
Q4 | $1.06M | Buy |
7,512
+141
| +2% | +$20.8K | 0.32% | 80 |
|
|
2016
Q3 | $1.17M | Buy |
7,371
+1,209
| +20% | +$186K | 0.39% | 64 |
|
|
2016
Q2 | $911K | Buy |
6,162
+125
| +2% | +$18.4K | 0.32% | 82 |
|
|
2016
Q1 | $855K | Buy |
6,037
+2,089
| +53% | +$280K | 0.32% | 88 |
|
|
2015
Q4 | $560K | Buy |
3,948
+39
| +1% | +$5.2K | 0.19% | 136 |
|
|
2015
Q3 | $478K | Sell |
3,909
-1,704
| -30% | -$222K | 0.2% | 130 |
|
|
2015
Q2 | $750K | Buy |
5,613
+983
| +21% | +$128K | 0.29% | 104 |
|
|
2015
Q1 | $622K | Buy |
4,630
+557
| +14% | +$71.8K | 0.26% | 108 |
|
|
2014
Q4 | $510K | Sell |
4,073
-1
| -0% | -$122 | 0.23% | 129 |
|
|
2014
Q3 | $496K | Buy |
4,074
+24
| +0.6% | +$2.92K | 0.28% | 101 |
|
|
2014
Q2 | $478K | Buy |
4,050
+102
| +3% | +$12K | 0.24% | 127 |
|
|
2014
Q1 | $475K | Buy |
3,948
+69
| +2% | +$8.2K | 0.26% | 121 |
|
|
2013
Q4 | $432K | Buy |
3,879
+226
| +6% | +$22.5K | 0.25% | 129 |
|
|
2013
Q3 | $337K | Buy |
3,653
+146
| +4% | +$13.2K | 0.24% | 135 |
|
|
2013
Q2 | $297K | Buy |
+3,507
| New | +$292K | 0.24% | 134 |
|
Other funds holding TMO
Advisor Partners's TMO Position: Q2 2022 in Review
Advisor Partners increased its Thermo Fisher Scientific (TMO) stake by 6.9% in Q2 2022, buying an estimated $622K and bringing the position to 17,432 shares worth $9.47M. The position accounts for 0.67% of the portfolio, ranked #23.
Advisor Partners first reported a position in TMO in Q2 2013 and has held it in 37 quarters since. The position peaked at $11.2M in Q4 2021. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.
- Advisor Partners held 17,432 shares of Thermo Fisher Scientific worth $9.47M as of Q2 2022.
- Advisor Partners bought 1,130 Thermo Fisher Scientific shares in Q2 2022, an estimated $622K.
- Thermo Fisher Scientific made up 0.67% of Advisor Partners's portfolio in Q2 2022, its #23 holding.
- Advisor Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 37 quarters since.
- Advisor Partners's Thermo Fisher Scientific position peaked at $11.2M in Q4 2021.
- 2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.